Sarcopenia

Open Access
The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
DAISUKE ABE, TAKAYUKI KIMURA, SATORU KOIKE, HISATOMO TAMAKI, SAYUMI KONYA, MAYA KAWAMOTO, MASAHIRO UMEMOTO, MITSUO SATO, MUTSUKAZU KITANO, TAKAHIRO WAKASAKI and RYUJI YASUMATSU

In Vivo September 2025, 39 (5) 2993-3000; DOI: https://doi.org/10.21873/invivo.14100
Open Access
Sarcopenia’s Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis
SOTARO FUKUHARA, TSUYOSHI KOBAYASHI, MICHINORI HAMAOKA, HONMYO NARUHIKO, KOICHI OISHI, YOSUKE NAMBA, KO OSHITA, KEISO MATSUBARA, DAISUKE TAKEI, RYOSUKE NAKANO, HIROSHI SAKAI, SHINTARO KURODA, HIROYUKI TAHARA, MASAHIRO OHIRA and HIDEKI OHDAN

In Vivo November 2024, 38 (6) 2827-2835; DOI: https://doi.org/10.21873/invivo.13763
Open Access
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia
SALVATORE LAVALLE, MARIA ROSARIA VALERIO, EDOARDO MASIELLO, VITTORIO GEBBIA and GIUSEPPINA SCANDURRA

In Vivo July 2024, 38 (4) 1520-1529; DOI: https://doi.org/10.21873/invivo.13602
Open Access
Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma
PI-HAN LIAO, YI-HSUAN CHUANG, FU-SHINE YANG, CHING-YUAN KUO, MING-CHUN MA, CHUN-KAI LIAO and MING-CHUNG WANG

In Vivo July 2023, 37 (4) 1847-1856; DOI: https://doi.org/10.21873/invivo.13276
Open Access
Sarcopenia and the Therapeutic Effects of Androgen Receptor-axis-targeted Therapies in Patients With Castration-resistant Prostate Cancer
TASUKU HIROSHIGE, NAOYUKI OGASAWARA, HISAJI KUMAGAE, KOSUKE UEDA, KATSUAKI CHIKUI, KEI-ICHIRO UEMURA, KIYOAKI NISHIHARA, MAKOTO NAKIRI, MITSUNORI MATSUO, SHIGETAKA SUEKANE and TSUKASA IGAWA

In Vivo May 2023, 37 (3) 1266-1274; DOI: https://doi.org/10.21873/invivo.13204
Open Access
Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma
TOMOYUKI MAKINO, KOUJI IZUMI, HIROAKI IWAMOTO, SUGURU KADOMOTO, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

In Vivo May 2023, 37 (3) 1304-1311; DOI: https://doi.org/10.21873/invivo.13209
Open Access
Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer
BEE-SONG CHANG, TAI-CHU PENG, KUN-HAN LUE, YI-FENG WU and CHUN-HOU HUANG

In Vivo May 2023, 37 (3) 1358-1364; DOI: https://doi.org/10.21873/invivo.13217
Open Access
Preoperative Psoas Muscle Thickness to Height Ratio Predicts Poor Survival After Resection of Biliary Tract Cancer
SHINICHI IKUTA, TSUKASA AIHARA, TAKAYOSHI NAKAJIMA, MEIDAI KASAI and NAOKI YAMANAKA

In Vivo March 2023, 37 (2) 879-886; DOI: https://doi.org/10.21873/invivo.13156
Open Access
Association Between the Neutrophil-to-Lymphocyte Ratio and Infection and Survival in Diffuse Large B Cell Lymphoma
MIN-FENG SHIH, KUN-HAN LUE, TSO-FU WANG, SUNG-CHAO CHU and CHUN-HOU HUANG

In Vivo March 2023, 37 (2) 948-954; DOI: https://doi.org/10.21873/invivo.13167
Open Access
Study of Therapeutic Effects of Losartan for Sarcopenia Based on the F344xBN Rat Aging Model
DONGHUN KANG, KIDEOK PARK and DAEYOUNG KIM

In Vivo November 2022, 36 (6) 2740-2750; DOI: https://doi.org/10.21873/invivo.13010

Main menu

User menu

Search

Sarcopenia

Pages